Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.

Wong KS, Lorch J, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta J.

Thyroid. 2019 Aug 9. doi: 10.1089/thy.2019.0263. [Epub ahead of print]

PMID:
31397224
2.

A Cohort Analysis of Clinical and Ultrasound Variables Predicting Cancer Risk in 20,001 Consecutive Thyroid Nodules.

Angell TE, Maurer R, Wang Z, Kim MI, Alexander CA, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Krane JF, Marqusee E, Moore FD, Nehs MA, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2019 Jul 16. pii: jc.2019-00664. doi: 10.1210/jc.2019-00664. [Epub ahead of print]

PMID:
31310316
3.

Gender disparities in award recipients from surgical specialty societies.

Atkinson R, Lu P, Cho NL, Melnitchouk N, Kuo LE.

Surgery. 2019 Sep;166(3):423-428. doi: 10.1016/j.surg.2019.04.021. Epub 2019 Jun 20.

PMID:
31229313
4.

Utility of Level III Axillary Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease.

Mahvi DA, Fairweather M, Yoon CH, Cho NL.

Ann Surg Oncol. 2019 Sep;26(9):2846-2854. doi: 10.1245/s10434-019-07509-2. Epub 2019 Jun 17.

PMID:
31209665
5.

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer.

Silva de Morais N, Stuart J, Guan H, Wang Z, Cibas ES, Frates MC, Benson CB, Cho NL, Nehs MA, Alexander CA, Marqusee E, Kim MI, Lorch JH, Barletta JA, Angell TE, Alexander EK.

J Endocr Soc. 2019 Mar 5;3(4):791-800. doi: 10.1210/js.2018-00427. eCollection 2019 Apr 1.

6.

The Posterior Adiposity Index: A Quantitative Selection Tool for Adrenalectomy Approach.

Lindeman B, Gawande AA, Moore FD Jr, Cho NL, Doherty GM, Nehs MA.

J Surg Res. 2019 Jan;233:26-31. doi: 10.1016/j.jss.2018.07.003. Epub 2018 Jul 26.

PMID:
30502257
7.

Diversity and inclusion in a surgical society: A longitudinal investigation.

Kuo LE, Parangi S, Cho NL.

Surgery. 2019 Apr;165(4):808-813. doi: 10.1016/j.surg.2018.10.027. Epub 2018 Dec 1.

PMID:
30509749
8.

Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.

Lindeman BM, Nehs MA, Angell TE, Alexander EK, Gawande AA, Moore FD Jr, Doherty GM, Cho NL.

Ann Surg Oncol. 2019 Jan;26(1):93-97. doi: 10.1245/s10434-018-6932-5. Epub 2018 Oct 19.

PMID:
30341576
9.

Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH.

Wang J, Cho NL, Zauber AG, Hsu M, Dawson D, Srivastava A, Mitchell-Richards KA, Markowitz SD, Bertagnolli MM.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):728-736. doi: 10.1158/1055-9965.EPI-17-0573. Epub 2018 May 16.

10.

Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old.

Wang Z, Vyas CM, Van Benschoten O, Nehs MA, Moore FD Jr, Marqusee E, Krane JF, Kim MI, Heller HT, Gawande AA, Frates MC, Doubilet PM, Doherty GM, Cho NL, Cibas ES, Benson CB, Barletta JA, Zavacki AM, Larsen PR, Alexander EK, Angell TE.

Thyroid. 2018 Apr;28(4):465-471. doi: 10.1089/thy.2017.0655. Epub 2018 Apr 2.

PMID:
29608439
11.

Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways.

Rosenberg L, Yoon CH, Sharma G, Bertagnolli MM, Cho NL.

Carcinogenesis. 2018 May 3;39(5):681-688. doi: 10.1093/carcin/bgy038.

PMID:
29538717
12.

Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.

Angell TE, Vyas CM, Barletta JA, Cibas ES, Cho NL, Doherty GM, Gawande AA, Howitt BE, Krane JF, Marqusee E, Strickland KC, Alexander EK, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.

PMID:
29520656
13.

4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease.

Hamidi M, Sullivan M, Hunter G, Hamberg L, Cho NL, Gawande AA, Doherty GM, Moore FD Jr, Nehs MA.

Ann Surg Oncol. 2018 May;25(5):1403-1409. doi: 10.1245/s10434-018-6367-z. Epub 2018 Feb 26.

PMID:
29484563
14.

Differential Growth Rates of Benign vs. Malignant Thyroid Nodules.

Angell TE, Vyas CM, Medici M, Wang Z, Barletta JA, Benson CB, Cibas ES, Cho NL, Doherty GM, Doubilet PM, Frates MC, Gawande AA, Heller HT, Kim MI, Krane JF, Marqusee E, Moore FD Jr, Nehs MA, Zavacki AM, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4642-4647. doi: 10.1210/jc.2017-01832.

PMID:
29040691
15.

Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.

Sullivan MC, Graham PH, Alexander EK, Ruan DT, Nehs MA, Gawande AA, Moore FD Jr, Howitt BE, Strickland KC, Krane JF, Barletta JA, Cho NL.

J Am Coll Surg. 2017 Jun;224(6):1021-1027. doi: 10.1016/j.jamcollsurg.2016.12.007. Epub 2016 Dec 23.

PMID:
28017809
16.

Clinical, Sonographic, and Pathological Characteristics of RAS-Positive Versus BRAF-Positive Thyroid Carcinoma.

Kakarmath S, Heller HT, Alexander CA, Cibas ES, Krane JF, Barletta JA, Lindeman NI, Frates MC, Benson CB, Gawande AA, Cho NL, Nehs M, Moore FD, Marqusee E, Kim MI, Larsen PR, Kwong N, Angell TE, Alexander EK.

J Clin Endocrinol Metab. 2016 Dec;101(12):4938-4944. Epub 2016 Sep 30.

17.

Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation.

Izar B, Joyce CE, Goff S, Cho NL, Shah PM, Sharma G, Li J, Ibrahim N, Gold J, Hodi FS, Garraway LA, Novina CD, Bertagnolli MM, Yoon CH.

Pigment Cell Melanoma Res. 2016 Nov;29(6):656-668. doi: 10.1111/pcmr.12513. Epub 2016 Sep 22.

PMID:
27482935
18.

Identification of Novel Oncogenic Mutations in Thyroid Cancer.

Pitt SC, Hernandez RA, Nehs MA, Gawande AA, Moore FD Jr, Ruan DT, Cho NL.

J Am Coll Surg. 2016 Jun;222(6):1036-1043.e2. doi: 10.1016/j.jamcollsurg.2015.12.047. Epub 2016 Jan 14.

PMID:
27010584
19.

Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis.

Liu X, Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Larsen PR, Cho NL, Nehs MA, Ruan DT, Gawande A, Moore F Jr, Barletta J, Krane JF, Cibas ES, Yang T, Alexander EK.

Thyroid. 2016 Feb;26(2):256-61. doi: 10.1089/thy.2015.0376. Epub 2015 Dec 16.

20.

The variable phenotype and low-risk nature of RAS-positive thyroid nodules.

Medici M, Kwong N, Angell TE, Marqusee E, Kim MI, Frates MC, Benson CB, Cibas ES, Barletta JA, Krane JF, Ruan DT, Cho NL, Gawande AA, Moore FD Jr, Alexander EK.

BMC Med. 2015 Aug 7;13:184. doi: 10.1186/s12916-015-0419-z.

21.

Antitumor effects of hyaluronan inhibition in desmoid tumors.

Briggs A, Rosenberg L, Buie JD, Rizvi H, Bertagnolli MM, Cho NL.

Carcinogenesis. 2015 Feb;36(2):272-9. doi: 10.1093/carcin/bgu324. Epub 2015 Jan 2.

PMID:
25556151
22.

False negative cytology in large thyroid nodules.

Giles WH, Maclellan RA, Gawande AA, Ruan DT, Alexander EK, Moore FD Jr, Cho NL.

Ann Surg Oncol. 2015 Jan;22(1):152-7. doi: 10.1245/s10434-014-3952-7. Epub 2014 Jul 30.

PMID:
25074665
23.

Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesis.

Hasson RM, Briggs A, Rizvi H, Carothers AM, Davids JS, Bertagnolli MM, Cho NL.

Biochem Biophys Res Commun. 2014 Feb 14;444(3):283-9. doi: 10.1016/j.bbrc.2013.11.135. Epub 2014 Jan 31.

PMID:
24486542
24.

Surgeons and patients disagree on the potential consequences from hypoparathyroidism.

Cho NL, Moalem J, Chen L, Lubitz CC, Moore FD Jr, Ruan DT.

Endocr Pract. 2014 May;20(5):427-46. doi: 10.4158/EP13321.OR.

PMID:
24325999
25.

Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling.

Hasson RM, Briggs A, Carothers AM, Davids JS, Wang J, Javid SH, Cho NL, Bertagnolli MM.

Carcinogenesis. 2014 Jan;35(1):96-102. doi: 10.1093/carcin/bgt323. Epub 2013 Oct 8.

26.

Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging.

Nehs MA, Ruan DT, Gawande AA, Moore FD Jr, Cho NL.

World J Surg. 2013 Jul;37(7):1614-7. doi: 10.1007/s00268-013-2007-8.

PMID:
23519294
27.

Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers.

Cho NL, Lin CI, Du J, Whang EE, Ito H, Moore FD Jr, Ruan DT.

Biochem Biophys Res Commun. 2012 May 11;421(3):508-13. doi: 10.1016/j.bbrc.2012.04.034. Epub 2012 Apr 10.

PMID:
22521882
28.

Bronchogenic cyst masquerading as an adrenal tumor: a case of mistaken identity.

O'Neal PB, Moore FD, Gawande A, Cho NL, King EE, Moalem J, Ruan D.

Endocr Pract. 2012 Sep-Oct;18(5):e102-5. doi: 10.4158/EP11186.CR. Review.

PMID:
22440987
29.

Hemorrhagic shock as the initial manifestation of pheochromocytoma: report of a sequential management strategy.

O'Neal PB, Moore FD Jr, Gawande A, Cho NL, Moalem J, Ruan DT.

Endocr Pract. 2012 Jul-Aug;18(4):e81-4. doi: 10.4158/EP11149.CR.

PMID:
22440984
30.

Necroptosis is a novel mechanism of radiation-induced cell death in anaplastic thyroid and adrenocortical cancers.

Nehs MA, Lin CI, Kozono DE, Whang EE, Cho NL, Zhu K, Moalem J, Moore FD Jr, Ruan DT.

Surgery. 2011 Dec;150(6):1032-9. doi: 10.1016/j.surg.2011.09.012.

PMID:
22136818
31.

Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Carothers AM, Rizvi H, Hasson RM, Heit YI, Davids JS, Bertagnolli MM, Cho NL.

Cancer Res. 2012 Jan 1;72(1):346-55. doi: 10.1158/0008-5472.CAN-11-2819. Epub 2011 Nov 17.

32.

Critical role of identification of the second gland during unilateral parathyroid surgery: a prospective review of 119 patients with concordant localization.

Cho NL, Gawande AA, Sheu EG, Moore FD Jr, Ruan DT.

Arch Surg. 2011 May;146(5):512-6. doi: 10.1001/archsurg.2011.91.

PMID:
21576603
33.

Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumors.

Cho NL, Carothers AM, Rizvi H, Hasson RM, Redston M, Bertagnolli MM.

J Surg Res. 2012 Apr;173(2):320-6. doi: 10.1016/j.jss.2010.10.037. Epub 2010 Nov 26.

PMID:
21195420
34.

Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.

Cho NL, Lin CI, Whang EE, Carothers AM, Moore FD Jr, Ruan DT.

Thyroid. 2010 Jun;20(6):615-22. doi: 10.1089/thy.2009.0415.

PMID:
20470206
35.

Career satisfaction of women in surgery: perceptions, factors, and strategies.

Ahmadiyeh N, Cho NL, Kellogg KC, Lipsitz SR, Moore FD Jr, Ashley SW, Zinner MJ, Breen EM.

J Am Coll Surg. 2010 Jan;210(1):23-8. doi: 10.1016/j.jamcollsurg.2009.08.011. Epub 2009 Oct 2.

PMID:
20123327
36.

Aberrant crypt foci in the adenoma prevention with celecoxib trial.

Cho NL, Redston M, Zauber AG, Carothers AM, Hornick J, Wilton A, Sontag S, Nishioka N, Giardiello FM, Saltzman JR, Gostout C, Eagle CJ, Hawk ET, Bertagnolli MM.

Cancer Prev Res (Phila). 2008 Jun;1(1):21-31. doi: 10.1158/1940-6207.CAPR-07-0011. Epub 2008 Apr 14.

37.

Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.

Cho NL, Javid SH, Carothers AM, Redston M, Bertagnolli MM.

Cancer Res. 2007 Mar 1;67(5):2366-72.

38.

Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.

Carothers AM, Moran AE, Cho NL, Redston M, Bertagnolli MM.

Cancer Res. 2006 Jun 15;66(12):6432-8.

39.

Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes.

Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M.

J Virol. 1997 Nov;71(11):8657-65.

40.

MR imaging of nasal masses.

Allbery SM, Chaljub G, Cho NL, Rassekh CH, John SD, Guinto FC.

Radiographics. 1995 Nov;15(6):1311-27. Review.

PMID:
8577959

Supplemental Content

Support Center